Symbol="MIRM"
AssetType="Common Stock"
Name="Mirum Pharmaceuticals Inc"
Description="Mirum Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the development and commercialization of an advanced line of novel therapies for debilitating liver diseases. The company is headquartered in Foster City, California."
CIK="1759425"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="950 TOWER LANE, SUITE 1050, FOSTER CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1032183000"
EBITDA="-121399000"
PERatio="None"
PEGRatio="None"
BookValue="3.713"
DividendPerShare="0"
DividendYield="0"
EPS="-3.64"
RevenuePerShareTTM="2.703"
ProfitMargin="-1.349"
OperatingMarginTTM="-1.312"
ReturnOnAssetsTTM="-0.257"
ReturnOnEquityTTM="-1.033"
RevenueTTM="95768000"
GrossProfitTTM="64688000"
DilutedEPSTTM="-3.64"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.451"
AnalystTargetPrice="54.43"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="12.6"
PriceToBookRatio="3.955"
EVToRevenue="9.3"
EVToEBITDA="-16.18"
Beta="1.266"
num_52WeekHigh="30.55"
num_52WeekLow="17.32"
num_50DayMovingAverage="26.84"
num_200DayMovingAverage="23.17"
SharesOutstanding="38031800"
DividendDate="None"
ExDividendDate="None"
symbol="MIRM"
open="28.04"
high="28.43"
low="26.75"
price="27.21"
volume="1668701.00"
latest_trading_day="2023-07-18"
previous_close="27.14"
change="0.07"
change_percent="0.2579%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="4"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="96"
Volume_recent_avg="522486"
Change_recent_avg="0.05"
Delta_recent_avg="1.11"
Variance_recent_avg="0.55"
Change_ratio_recent_avg="0.18"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="96"
Aroon_momentum_negative="4"
image_negative_thumbnail_id_1="516"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0089.jpeg"
image_negative_thumbnail_id_2="148"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0028.jpeg"
image_neutral_thumbnail_id_1="539"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0060.jpeg"
image_neutral_thumbnail_id_2="557"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0042.jpeg"
image_positive_thumbnail_id_1="959"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0121.jpeg"
image_positive_thumbnail_id_2="963"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0125.jpeg"
image_professor_thumbnail_id_1="1188"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
